<DOC>
	<DOCNO>NCT01961804</DOCNO>
	<brief_summary>The occurence minor craniocerebral trauma patient receive vitamine K antagonist treatment lead high risk bleeding . Current guideline recommend perform CT scan , , case intracranial bleeding , reverse anticoagulation concomitant administration prothrombin complex concentrate ( PCCs ) vitamin K. However , even reversion perform , prognostic post-traumatic intracranial bleeding remain bad . The investigator hypothesize , patient admit emergency department minor head trauma receive anticoagulant treatment , systematic preventive reversion PCCs lead significant reduction intracranial haemorrhage also improve neurological prognostic patient versus current strategy . PREVACT test hypothesis , open label , randomize , multicentre , clinical trial involve 400 patient .</brief_summary>
	<brief_title>PREVACT : Preventive REversal Vitamine K Antagonist Minor Craniocerebral Trauma</brief_title>
	<detailed_description />
	<mesh_term>Hemorrhage</mesh_term>
	<mesh_term>Craniocerebral Trauma</mesh_term>
	<mesh_term>Vitamins</mesh_term>
	<mesh_term>Vitamin K</mesh_term>
	<criteria>Admission emergency departement recent isolate minor head trauma least one follow characteristic : period alteration level consciousness , period loss consciousness ( &lt; 30 min ) , posttraumatic amnesia , persistant posttraumatic headache , repeat vomitting ( least 2 episode ) neurological sign convulsion localise neurological sign ... Subject receive anticoagulant treatment antivitamin K treatment atrial fibrillation ( AF ) Initial ED Glasgow Coma Scale ( GCS ) score ≥13 Achievable follow Informed consent form sign patient he/she n't able emergency inclusion realise . Delay minor head trauma possible preventive PCC 's administration &gt; 6h Subject receive anticoagulant treatment anti vitamin K ( heparin , fondaparinux , dabigatran , rivaroxaban , apixaban ... ) Subject receive anticoagulant treatment reason AF Subject antiplatelet treatment ( except use low dose aspirin ( ≤ 100 mg/day ) Delocalised biology INR capillary blood &lt; 1.5 's available ( departement analyse usual practice ) Haemorrhage suspect haemorrhage intracranial could lead reversion anticoagulation Head trauma associate one potential haemorrhagic traumatic lesion Subject reject use product derive human blood Women pregnant Subject condition , judge investigator , would place subject increase risk harm he/she participate study Subject without social security register</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2016</verification_date>
</DOC>